Form 8-K - Current report:
SEC Accession No. 0001193125-24-070701
Filing Date
2024-03-19
Accepted
2024-03-19 06:24:03
Documents
20
Period of Report
2024-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d739068d8k.htm   iXBRL 8-K 63006
2 EX-2.1 d739068dex21.htm EX-2.1 910673
3 EX-3.1 d739068dex31.htm EX-3.1 6479
4 EX-10.1 d739068dex101.htm EX-10.1 7373
5 EX-99.1 d739068dex991.htm EX-99.1 55401
6 EX-99.2 d739068dex992.htm EX-99.2 21332
7 EX-99.3 d739068dex993.htm EX-99.3 13611
11 GRAPHIC g739068g0319084729642.jpg GRAPHIC 3767
  Complete submission text file 0001193125-24-070701.txt   1460625

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fusn-20240318.xsd EX-101.SCH 2854
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20240318_lab.xml EX-101.LAB 19435
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20240318_pre.xml EX-101.PRE 12141
23 EXTRACTED XBRL INSTANCE DOCUMENT d739068d8k_htm.xml XML 4009
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 24761030
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)